Abciximab in Emergent Stroke Treatment Trial "AbESTT"

Completed

Phase 3 Results

Summary of Purpose

To determine the safety of abciximab in acute stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 October 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Eli Lilly and Company Indianapolis

Trial Design

Randomized, double-blind, placebo-controlled trial.

Contacts

Not available